Generali, D., Buffa, F., Berruti, A., Brizzi, M., Campo, L., Bonardi, S., . . . Fox, S. (2009). Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
Chicago Style (17th ed.) CitationGenerali, D., et al. Phosphorylated ERalpha, HIF-1alpha, and MAPK Signaling as Predictors of Primary Endocrine Treatment Response and Resistance in Patients with Breast Cancer. 2009.
MLA引文Generali, D., et al. Phosphorylated ERalpha, HIF-1alpha, and MAPK Signaling as Predictors of Primary Endocrine Treatment Response and Resistance in Patients with Breast Cancer. 2009.
警告：這些引文格式不一定是100％准確.